← Leaderboards
Angus C. Nairn
Rockefeller University
$15,314,298
Attributed
$17,614,482
Total exposure
28
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,437,925 · 29
By mechanism
P30$22,178,022 · 4
P01$6,774,273 · 7
R01$3,450,276 · 1
P50$2,491,794 · 2
R21$367,500 · 1
R03$147,000 · 1
Top collaborators
- Kenneth Robert Williams11 shared
- Steven E Arnold5 shared
- Becky Catherine Carlyle5 shared
Most similar at Rockefeller University
Same institution · by research overlap
- Suzanne Margaret Leal$29,725,759
- Paul Greengard$29,785,859
- Samuel E Gandy$18,006,077
- Hong Wang$127,972
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsProteomicsBrainNeuronsMolecularSignal TransductionAlzheimer&AposPhosphorylationBaseCellsCollaborationsProgramsResearch PersonnelPropertyPlayRegulationMediatingPeptidesStructureLeadS DiseaseGene ExpressionBiological MarkersFuture
Grant awards (83)
Yale/NIDA Neuroproteomics Center$1,857,701
P30 · FY2025 · DA
Bioinformatics and Biostatistics Core$357,056
P30 · FY2025 · DA · contact PI
Yale/NIDA Neuroproteomics Center$1,616,094
P30 · FY2024 · DA
Biomarker Core$670,001
P30 · FY2024 · AG · contact PI
Bioinformatics and Biostatistics Core$331,208
P30 · FY2024 · DA · contact PI
Yale/NIDA Neuroproteomics Center$1,616,094
P30 · FY2023 · DA
Biomarker Core$418,749
P30 · FY2023 · AG · contact PI
Bioinformatics and Biostatistics Core$327,691
P30 · FY2023 · DA · contact PI
Yale/NIDA Neuroproteomics Center$1,616,094
P30 · FY2022 · DA
Biomarker Core$418,750
P30 · FY2022 · AG · contact PI
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$400,779
R01 · FY2022 · AG
Bioinformatics and Biostatistics Core$331,208
P30 · FY2022 · DA · contact PI
Yale/NIDA Neuroproteomics Center$1,616,094
P30 · FY2021 · DA
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$750,020
R01 · FY2021 · AG
Biomarker Core$418,750
P30 · FY2021 · AG · contact PI
Bioinformatics and Biostatistics Core$331,208
P30 · FY2021 · DA · contact PI
Role of MAST3 kinase in developmental and epileptic encephalopathy$147,000
R03 · FY2021 · TR · contact PI
Yale/NIDA Neuroproteomics Center$1,616,094
P30 · FY2020 · DA
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$762,826
R01 · FY2020 · AG
Biomarker Core$418,750
P30 · FY2020 · AG · contact PI
Bioinformatics and Biostatistics Core$331,208
P30 · FY2020 · DA · contact PI
Yale/NIDA Neuroproteomics Center$1,559,655
P30 · FY2019 · DA
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$761,448
R01 · FY2019 · AG
Biomarker/Pathology Core$212,344
P50 · FY2019 · AG · contact PI
Yale/NIDA Neuroproteomics Center$1,544,774
P30 · FY2018 · DA
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$775,203
R01 · FY2018 · AG
Biomarker/Pathology Core$214,056
P50 · FY2018 · AG · contact PI
Yale/NIDA Neuroproteomics Center$1,548,122
P30 · FY2017 · DA
Biomarker/Pathology Core$215,894
P50 · FY2017 · AG · contact PI
Cell-type Specific Psychostimulant Effects on the Neuronal Translatome$183,750
R21 · FY2017 · DA · contact PI
Yale/NIDA Neuroproteomics Center$1,519,226
P30 · FY2016 · DA
Biomarker/Pathology Core$215,657
P50 · FY2016 · AG · contact PI
Cell-type Specific Psychostimulant Effects on the Neuronal Translatome$183,750
R21 · FY2016 · DA · contact PI
Yale/NIDA Neuroproteomics Center$1,713,495
P30 · FY2015 · DA
P3 - Striatal Phosphoproteins and the Actions of Psychostimulants$346,897
P01 · FY2015 · DA · contact PI
Biomarker/Pathology Core$216,530
P50 · FY2015 · AG · contact PI
Biochemical Mechanisms Mediating Cell Type-Specific Actions of Antipsychotic Drug$257,397
P50 · FY2014 · MH · contact PI
P3 - Striatal Phosphoproteins and the Actions of Psychostimulants$252,475
P01 · FY2014 · DA · contact PI
P3 - Striatal Phosphoproteins and the Actions of Psychostimulants$345,128
P01 · FY2013 · DA · contact PI
Biochemical Mechanisms Mediating Cell Type-Specific Actions of Antipsychotic Drug$306,255
P50 · FY2013 · MH · contact PI
Biochemical Mechanisms Mediating Cell Type-Specific Actions of Antipsychotic Drug$319,014
P50 · FY2012 · MH · contact PI
P3 - Striatal Phosphoproteins and the Actions of Psychostimulants$254,309
P01 · FY2012 · DA · contact PI
MICRO-ARRAY ANALYSIS, PROTEOMICS, AND VIRAL MANIPULATION OF cAMP SIGNALING IN AGI$164,784
P01 · FY2012 · AG · contact PI
ROLE OF CK1 IN ALZHEIMER'S DISEASE ETIOLOGY$369,787
P01 · FY2011 · AG · contact PI
MICRO-ARRAY ANALYSIS, PROTEOMICS, AND VIRAL MANIPULATION OF cAMP SIGNALING IN AGI$329,642
P01 · FY2011 · AG · contact PI
P3 - Striatal Phosphoproteins and the Actions of Psychostimulants$294,378
P01 · FY2011 · DA · contact PI
Biochemical Mechanisms Mediating Cell Type-Specific Actions of Antipsychotic Drug$257,398
P50 · FY2011 · MH · contact PI
CDK5/P35 PHOSPHORYLATION$1,304
P41 · FY2011 · RR · contact PI
Striatal Phosphoproteins and the Actions of the Psychostimulants$421,294
P01 · FY2010 · DA · contact PI
ROLE OF CK1 IN ALZHEIMER'S DISEASE ETIOLOGY$373,541
P01 · FY2010 · AG · contact PI
Biochemical Mechanisms Mediating Cell Type-Specific Actions of Antipsychotic Drug$277,249
P50 · FY2010 · MH · contact PI
MICRO-ARRAY ANALYSIS, PROTEOMICS, AND VIRAL MANIPULATION OF cAMP SIGNALING IN AGI$259,928
P01 · FY2010 · AG · contact PI
CDK5/P35 PHOSPHORYLATION$1,167
P41 · FY2010 · RR · contact PI
Striatal Phosphoproteins and the Actions of the Psychostimulants$418,113
P01 · FY2009 · DA · contact PI
ROLE OF CK1 IN ALZHEIMER'S DISEASE ETIOLOGY$306,026
P01 · FY2009 · AG · contact PI
MICRO-ARRAY ANALYSIS, PROTEOMICS, AND VIRAL MANIPULATION OF cAMP SIGNALING IN AGI$273,435
P01 · FY2009 · AG · contact PI
CDK5/P35 PHOSPHORYLATION$1,190
P41 · FY2009 · RR · contact PI
Striatal Phosphoproteins and the Actions of the Psychostimulants$405,327
P01 · FY2008 · DA · contact PI
ROLE OF CK1 IN ALZHEIMER'S DISEASE ETIOLOGY$296,749
P01 · FY2008 · AG · contact PI
MICRO-ARRAY ANALYSIS, PROTEOMICS, AND VIRAL MANIPULATION OF cAMP SIGNALING IN AGI$187,897
P01 · FY2008 · AG · contact PI
CDK5/P35 PHOSPHORYLATION$1,102
P41 · FY2008 · RR · contact PI
Striatal Phosphoproteins and the Actions of the Psychostimulants$387,722
P01 · FY2007 · DA · contact PI
ROLE OF CK1 IN ALZHEIMER'S DISEASE ETIOLOGY$293,038
P01 · FY2007 · AG · contact PI
ID OF IN VITRO PHOSPHORYLATION SITES WITHIN ELONGATION FACTOR 2 KINASE$3,767
P41 · FY2007 · RR · contact PI
IN VITRO AUTOPHOSPHORYLATION SITES WITHIN CHAK,CALCIUM CHANNEL$1,920
P41 · FY2007 · RR · contact PI
CDK5/P35 PHOSPHORYLATION$1,883
P41 · FY2007 · RR · contact PI
STRIATAL PHOSPHOPROTEINS AND THE ACTIONS OF PSYCHOSTIMULANTS$256,444
P01 · FY2006 · DA · contact PI
ID OF IN VITRO PHOSPHORYLATION SITES WITHIN ELONGATION FACTOR 2 KINASE$2,466
P41 · FY2006 · RR · contact PI
CDK5/P35 PHOSPHORYLATION$1,233
P41 · FY2006 · RR · contact PI
IN VITRO AUTOPHOSPHORYLATION SITES WITHIN CHAK,CALCIUM CHANNEL$1,233
P41 · FY2006 · RR · contact PI
ID OF IN VITRO PHOSPHORYLATION SITES WITHIN ELONGATION FACTOR 2 KINASE$2,380
P41 · FY2005 · RR
CDK5/P35 PHOSPHORYLATION$1,190
P41 · FY2005 · RR
IN VITRO AUTOPHOSPHORYLATION SITES WITHIN CHAK,CALCIUM CHANNEL$1,190
P41 · FY2005 · RR
PHOSPHORYLATION SITES WITHIN ELONGATION FACTOR 2 KINASE$2,345
P41 · FY2004 · RR
CDK5/P35 PHOSPHORYLATION$2,345
P41 · FY2004 · RR
AUTOPHOSPHORYLATION SITES WITHIN CHAK, CALCIUM CHANNEL$2,345
P41 · FY2004 · RR
BIOCHEMICAL ANALYSIS OF BASAL GANGLIA PHOSPHOPROTEINS$0
P01 · FY2002 · MH
DARPP-16 &DARPP-21 IN MEDIATING THE ACTIONS OF DRUGS OF ABUSE$0
P01 · FY2002 · DA
BIOCHEMICAL ANALYSIS OF BASAL GANGLIA PHOSPHOPROTEINS$0
P01 · FY2001 · MH
DARPP-16 &DARPP-21 IN MEDIATING THE ACTIONS OF DRUGS OF ABUSE$0
P01 · FY2001 · DA
THE ROLE OF DARPPS IN THE ACUTE AND CHRONIC EFFECTS OF COCAINE AND AMPHETAMINE$295,779
P01 · FY2000 · DA
PROTEIN CHEMICAL STUDIES OF AMYLOID PRECURSOR PROTEIN$241,580
P01 · FY2000 · AG
BIOCHEMICAL ANALYSIS OF BASAL GANGLIA PHOSPHOPROTEINS$0
P01 · FY2000 · MH